Literature DB >> 10400801

Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.

C Liang1, L Rong, Y Quan, M Laughrea, L Kleiman, M A Wainberg.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) genomic RNA segments at nucleotide (nt) positions +240 to +274 are thought to form a stem-loop secondary structure, termed SL1, that serves as a dimerization initiation site for viral genomic RNA. We have generated two distinct deletion mutations within this region, termed BH10-LD3 and BH10-LD4, involving nt positions +238 to +253 and +261 to +274, respectively, and have shown that each of these resulted in significant diminutions in levels of viral infectiousness. However, long-term culture of each of these viruses in MT-2 cells resulted in a restoration of infectiousness, due to a series of compensatory point mutations within four distinct proteins that are normally cleaved from the Gag precursor. In the case of BH10-LD3, these four mutations were MA1, CA1, MP2, and MNC, and they involved changes of amino acid Val-35 to Ile within the matrix protein (MA), Ile-91 to Thr within the capsid (CA), Thr-12 to Ile within p2, and Thr-24 to Ile within the nucleocapsid (NC). The order in which these mutations were acquired by the mutated BH10-LD3 was MNC > CA1 > MP2 > MA1. The results of site-directed mutagenesis studies confirmed that each of these four substitutions contributed to the increased viability of the mutated BH10-LD3 viruses and that the MNC substitution, which was acquired first, played the most important role in this regard. Three point mutations, MP2, MNC, and MA2, were also shown to be sequentially acquired by viruses that had emerged in culture from the BH10-LD4 deletion. The first two of these were identical to those described above, while the last involved a change of Val-35 to Leu. All three of these substitutions were necessary to restore the infectiousness of mutated BH10-LD4 viruses to wild-type levels, although the MP2 mutation alone, but neither of the other two substitutions, was able to confer some viability on BH10-LD4 viruses. Studies of viral RNA packaging showed that the BH10-LD4 deletion only marginally impaired encapsidation while the BH10-LD3 deletion caused a severe deficit in this regard.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400801      PMCID: PMC112788     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Molecular recognition in the HIV-1 capsid/cyclophilin A complex.

Authors:  S Yoo; D G Myszka; C Yeh; M McMurray; C P Hill; W I Sundquist
Journal:  J Mol Biol       Date:  1997-06-27       Impact factor: 5.469

2.  The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.

Authors:  G P Harrison; A M Lever
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  K Sakaguchi; N Zambrano; E T Baldwin; B A Shapiro; J W Erickson; J G Omichinski; G M Clore; A M Gronenborn; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

4.  Mode of dimerization of HIV-1 genomic RNA.

Authors:  G Awang; D Sen
Journal:  Biochemistry       Date:  1993-10-26       Impact factor: 3.162

5.  Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.

Authors:  R D Berkowitz; J Luban; S P Goff
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  A short sequence upstream of the 5' major splice site is important for encapsidation of HIV-1 genomic RNA.

Authors:  H J Kim; K Lee; J J O'Rear
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

7.  Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site.

Authors:  R Marquet; J C Paillart; E Skripkin; C Ehresmann; B Ehresmann
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

8.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.

Authors:  A Lever; H Gottlinger; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains.

Authors:  F Baudin; R Marquet; C Isel; J L Darlix; B Ehresmann; C Ehresmann
Journal:  J Mol Biol       Date:  1993-01-20       Impact factor: 5.469

10.  The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.

Authors:  R J Gorelick; D J Chabot; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  21 in total

1.  Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

Authors:  C Liang; L Rong; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging.

Authors:  N Shen; L Jetté; C Liang; M A Wainberg; M Laughrea
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Authors:  Serena Bernacchi; Ekram W Abd El-Wahab; Noé Dubois; Marcel Hijnen; Redmond P Smyth; Johnson Mak; Roland Marquet; Jean-Christophe Paillart
Journal:  RNA Biol       Date:  2016-11-14       Impact factor: 4.652

4.  Partial restoration of replication of simian immunodeficiency virus by point mutations in either the dimerization initiation site (DIS) or Gag region after deletion mutagenesis within the DIS.

Authors:  Y Guan; K Diallo; M Detorio; J B Whitney; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Hydrophobic amino acids in the human immunodeficiency virus type 1 p2 and nucleocapsid proteins can contribute to the rescue of deleted viral RNA packaging signals.

Authors:  L Rong; R S Russell; J Hu; Y Guan; L Kleiman; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Role of MxB in Alpha Interferon-Mediated Inhibition of HIV-1 Infection.

Authors:  Bin Xu; Qinghua Pan; Chen Liang
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

7.  Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequences.

Authors:  Y Guan; J B Whitney; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus.

Authors:  Y Guan; J B Whitney; K Diallo; M A Wainberg
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus.

Authors:  James B Whitney; Maureen Oliveira; Mervi Detorio; Yongjun Guan; Mark A Wainberg
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  The dimer initiation sequence stem-loop of human immunodeficiency virus type 1 is dispensable for viral replication in peripheral blood mononuclear cells.

Authors:  M K Hill; M Shehu-Xhilaga; S M Campbell; P Poumbourios; S M Crowe; J Mak
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.